Triple negative breast cancer (TNBC), characterized by the lack of expression of the estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) [4], tends to display a more aggressive clinical course with frequent distant recurrence and thus poor prognosis compared to other breast cancer types [5]. This evidence concerns the gene PGR and triple-negative breast carcinoma.